Insights into the diagnosis and management of iron deficiency in inflammatory bowel disease

References

• Ordas I, Eckmann L, Talamini M, et al. Ulcerative colitis. Lancet. 2012;380(9853):1606–1619.
   PubMed Web of Science ®Google Scholar
• Baumgart DC, Sandborn WJ. Crohn’s disease. Lancet. 2012;380(9853):1590–1605.
   PubMed Web of Science ®Google Scholar
• Ott C, Scholmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10(10):585–595.
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Williet N, Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015;102(6):1585–1594.
   PubMed Web of Science ®Google Scholar
• Goldberg ND. Iron deficiency anemia in patients with inflammatory bowel disease. Clin Exp Gastroenterol. 2013;6:61–70.
   PubMedGoogle Scholar
• Ott C, Liebold A, Takses A, et al. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort. Gastroenterol Res Pract. 2012;2012:595970.
   PubMed Web of Science ®Google Scholar
• Viprakasit V, Tyan P, Rodmai S, et al. Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition. Orphanet J Rare Dis. 2014;9(1):1–11.
   PubMed Web of Science ®Google Scholar
• Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427–434.
   PubMed Web of Science ®Google Scholar
• Mucke V, Mucke MM, Raine T, et al. Diagnosis and treatment of anemia in patients with inflammatory bowel disease. Ann Gastroenterol. 2017;30(1):15–22.
   PubMed Web of Science ®Google Scholar
• Kulnigg S, Gasche C. Systematic review: managing anaemia in Crohn’s disease. Aliment Pharmacol Ther. 2006;24(11–12):1507–1523.
   PubMed Web of Science ®Google Scholar
• Stein J, Hartmann F, Dignass AU. Diagnosis and management of iron deficiency anemia in patients with IBD. Nat Rev Gastroenterol Hepatol. 2010;7(11):599–610 .
   PubMed Web of Science ®Google Scholar
• Murawska N, Fabisiak A, Fichna J. Anemia of chronic disease and iron deficiency anemia in inflammatory bowel diseases: pathophysiology, diagnosis, and treatment. Inflamm Bowel Dis. 2016;22(5):1198–1208.
   PubMed Web of Science ®Google Scholar
• Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–1023.
   PubMed Web of Science ®Google Scholar
• Headstrom PD, Rulyak SJ, Lee SD. Prevalence of and risk factors for vitamin B(12) deficiency in patients with Crohn’s disease. Inflamm Bowel Dis. 2008;14(2):217–223.
   PubMed Web of Science ®Google Scholar
• Ward MG, Kariyawasam VC, Mogan SB, et al. Prevalence and risk factors for functional vitamin B12 deficiency in patients with Crohn’s disease. Inflamm Bowel Dis. 2015;21(12):2839–2847.
   PubMed Web of Science ®Google Scholar
• M’Koma AE. Follow-up results of hematology data before and after restorative proctocolectomy. Clinical outcome. Dis Colon Rectum. 1994;37(9):932–937.
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Gomollon F. Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review. Am J Gastroenterol. 2008;103(7):1783–1800.
   PubMed Web of Science ®Google Scholar
• Ransford RA, Langman MJ. Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut. 2002;51(4):536–539.
   PubMed Web of Science ®Google Scholar
• Gasche C, Lomer M, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53(8):1190–1197.
   PubMed Web of Science ®Google Scholar
• Guagnozzi D, Lucendo AJ. Anemia in inflammatory bowel disease: a neglected issue with relevant effects. World J Gastroenterol. 2014;20(13):3542–3551.
   PubMed Web of Science ®Google Scholar
• Danese S, Hoffman C, Vel S, et al. Anaemia from a patient perspective in inflammatory bowel disease: results from the European Federation of Crohn’s and Ulcerative Colitis Association’s online survey. Eur J Gastroenterol Hepatol. 2014;26(12):1385–1391.
   PubMed Web of Science ®Google Scholar
• Oustamanolakis P, Koutroubakis IE. Soluble transferrin receptor-ferritin index is the most efficient marker for the diagnosis of iron deficiency anemia in patients with IBD. Inflamm Bowel Dis. 2011;17(12):E158–E159.
   PubMed Web of Science ®Google Scholar
• Infusino I, Braga F, Dolci A, et al. Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis. Am J Clin Pathol. 2012;138(5):642–649.
   PubMed Web of Science ®Google Scholar
• Skikne BS, Punnonen K, Caldron PH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011;86(11):923–927.
   PubMed Web of Science ®Google Scholar
• Lopez A, Cacoub P, Macdougall IC, et al. Iron deficiency anaemia. Lancet. 2016;387(10021):907–916 .
   PubMed Web of Science ®Google Scholar
• Archer NM, Brugnara C. Diagnosis of iron-deficient states. Crit Rev Clin Lab Sci. 2015;52(5):256–272.
   PubMed Web of Science ®Google Scholar
• Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31–38.
   PubMed Web of Science ®Google Scholar
• Polin V, Coriat R, Perkins G, et al. Iron deficiency: from diagnosis to treatment. Dig Liver Dis. 2013;45(10):803–809.
   PubMedGoogle Scholar
• Gisbert JP, Gomollon F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroenterol. 2008;103(5):1299–1307.
   PubMed Web of Science ®Google Scholar
• Voudoukis E, Karmiris K, Oustamanolakis P, et al. Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2013;25(10):1212–1216.
   PubMed Web of Science ®Google Scholar
• Cronin CC, Shanahan F. Anemia in patients with chronic inflammatory bowel disease. Am J Gastroenterol. 2001;96(8):2296–2298.
   PubMed Web of Science ®Google Scholar
• Gasche C, Lomer MC, Cavill I, et al. Iron, anaemia, and inflammatory bowel diseases. Gut. 2004;53(8):1190–1197.
   PubMed Web of Science ®Google Scholar
• Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60(5):571–607.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Dignass A, Bokemeyer B, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013;7(1):1–33.
   PubMed Web of Science ®Google Scholar
• Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9(3):211–222.
   PubMed Web of Science ®Google Scholar
• Magro F, Ramos J, Correia L, et al. [Portuguese consensus on the diagnosis, prevention and treatment of anaemia in inflammatory bowel disease]. Acta Med Port. 2016;29(2):144–156.
   PubMed Web of Science ®Google Scholar
• Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;373(5):485–486.
   PubMed Web of Science ®Google Scholar
• Schroder O, Mickisch O, Seidler U, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease–a randomized, controlled, open-label, multicenter study. Am J Gastroenterol. 2005;100(11):2503–2509.
   PubMed Web of Science ®Google Scholar
• Keating GM. Ferric carboxymaltose: a review of its use in iron deficiency. Drugs. 2015;75(1):101–127.
   PubMed Web of Science ®Google Scholar
• Jimenez K, Kulnigg-Dabsch S, Gasche C. Management of iron deficiency anemia. Gastroenterol Hepatol (NY). 2015;11(4):241–250.
   PubMedGoogle Scholar
• Gomollon F, Gisbert JP. Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide. Drugs. 2013;73(16):1761–1770.
   PubMed Web of Science ®Google Scholar
• Kulnigg S, Stoinov S, Simanenkov V, et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial. Am J Gastroenterol. 2008;103(5):1182–1192.
   PubMed Web of Science ®Google Scholar
• Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13(12):1545–1553.
   PubMed Web of Science ®Google Scholar
• de Silva AD, Tsironi E, Feakins RM, et al. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther. 2005;22(11–12):1097–1105.
   PubMed Web of Science ®Google Scholar
• Akpinar H, Cetiner M, Keshav S, et al. Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report. Turk J Gastroenterol. 2017;28(2):81–87.
   PubMed Web of Science ®Google Scholar
• Leonard AJ, Chalmers KA, Collins CE, et al. Comparison of two doses of elemental iron in the treatment of latent iron deficiency: efficacy, side effects and blinding capabilities. Nutrients. 2014;6(4):1394–1405.
   PubMed Web of Science ®Google Scholar
• Santiago P. Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview. ScientificWorldJournal. 2012;2012:846824 .
   PubMed Web of Science ®Google Scholar
• Short MW, Domagalski JE. Iron deficiency anemia: evaluation and management. Am Fam Physician. 2013;87(2):98–104.
   PubMed Web of Science ®Google Scholar
• Ruiz-Arguelles GJ, Diaz-Hernandez A, Manzano C, et al. Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia. Hematology. 2007;12(3):255–256.
   PubMed Web of Science ®Google Scholar
• Kaltwasser JP, Werner E, Niechzial M. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations. Arzneimittelforschung. 1987;37(1A):122–129.
   PubMed Web of Science ®Google Scholar
• Malhotra S, Garg SK, Khullar GK, et al. Kinetics of two different iron formulations and their effect on diurnal variation of serum iron levels. Methods Find Exp Clin Pharmacol. 2004;26(6):417–420.
   PubMedGoogle Scholar
• Mehta BC. Ineffectiveness of iron polymaltose in treatment of iron deficiency anemia. J Assoc Physicians India. 2003;51:419–421.
   PubMedGoogle Scholar
• Gasche C, Ahmad T, Tulassay Z, et al. Ferric maltol is effective in correcting iron deficiency anemia in patients with inflammatory bowel disease: results from a phase-3 clinical trial program. Inflamm Bowel Dis. 2015;21(3):579–588.
   PubMed Web of Science ®Google Scholar
• Schmidt C, Ahmad T, Tulassay Z, et al. Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study. Aliment Pharmacol Ther. 2016;44(3):259–270.
   PubMed Web of Science ®Google Scholar
• Hershko C, Camaschella C. How I treat unexplained refractory iron deficiency anemia. Blood. 2014;123(3):326–333.
   PubMed Web of Science ®Google Scholar
• Schröder O, Mickisch O, Seidler U, et al. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease—a randomized, controlled, open-label, multicenter study. Am J Gastroenterol. 2005;100(11):2503–2509.
   PubMed Web of Science ®Google Scholar
• Reinisch W, Staun M, Bhandari S, et al. State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease. J Crohns Colitis. 2013;7(6):429–440.
   PubMed Web of Science ®Google Scholar
• Tompkins GR, O’Dell NL, Bryson IT, et al. The effects of dietary ferric iron and iron deprivation on the bacterial composition of the mouse intestine. Curr Microbiol. 2001;43(1):38–42.
   PubMed Web of Science ®Google Scholar
• Werner T, Wagner SJ, Martinez I, et al. Depletion of luminal iron alters the gut microbiota and prevents Crohn’s disease-like ileitis. Gut. 2011;60(3):325–333.
   PubMed Web of Science ®Google Scholar
• Carrier J, Aghdassi E, Platt I, et al. Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther. 2001;15(12):1989–1999.
   PubMed Web of Science ®Google Scholar
• Munoz M, Gomez-Ramirez S, Garcia-Erce JA. Intravenous iron in inflammatory bowel disease. World J Gastroenterol. 2009;15(37):4666–4674.
   PubMed Web of Science ®Google Scholar
• Seril DN, Liao J, Ho KL, et al. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci. 2002;47(6):1266–1278.
   PubMed Web of Science ®Google Scholar
• Blakeborough MH, Owen RW, Bilton RF. Free radical generating mechanisms in the colon: their role in the induction and promotion of colorectal cancer? Free Radic Res Commun. 1989;6(6):359–367.
   PubMed Web of Science ®Google Scholar
• Babbs CF. Free radicals and the etiology of colon cancer. Free Radic Biol Med. 1990;8(2):191–200.
   PubMed Web of Science ®Google Scholar
• Troost FJ, Brummer RJ, Dainty JR, et al. Iron supplements inhibit zinc but not copper absorption in vivo in ileostomy subjects. Am J Clin Nutr. 2003;78(5):1018–1023.
   PubMed Web of Science ®Google Scholar
• Lee TW, Kolber MR, Fedorak RN, et al. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis. 2012;6(3):267–275.
   PubMed Web of Science ®Google Scholar
• Gisbert JP, Bermejo F, Pajares R, et al. Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement. Inflamm Bowel Dis. 2009;15(10):1485–1491.
   PubMed Web of Science ®Google Scholar
• Schreiber S, Howaldt S, Schnoor M, et al. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease. N Engl J Med. 1996;334(10):619–623.
   PubMed Web of Science ®Google Scholar
• Moreno Lopez R, Sicilia Aladren B, Gomollon Garcia F. Use of agents stimulating erythropoiesis in digestive diseases. World J Gastroenterol. 2009;15(37):4675–4685.
   PubMed Web of Science ®Google Scholar
• Unger EF, Thompson AM, Blank MJ, et al. Erythropoiesis-stimulating agents–time for a reevaluation. N Engl J Med. 2010;362(3):189–192.
   PubMed Web of Science ®Google Scholar
• Kaitha S, Bashir M, Ali T. Iron deficiency anemia in inflammatory bowel disease. World J Gastrointest Pathophysiol. 2015;6(3):62–72.
   PubMedGoogle Scholar
• Kulnigg S, Teischinger L, Dejaco C, et al. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol. 2009;104(6):1460–1467.
   PubMed Web of Science ®Google Scholar
• Goddard AF, James MW, McIntyre AS, et al. British Society of G. Guidelines for the management of iron deficiency anaemia. Gut. 2011;60(10):1309–1316.
   PubMed Web of Science ®Google Scholar
• Sun CC, Vaja V, Babitt JL, et al. Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation. Am J Hematol. 2012;87(4):392–400.
   PubMed Web of Science ®Google Scholar
• Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012;1823(9):1434–1443.
   PubMed Web of Science ®Google Scholar
• Wessling-Resnick M. Iron homeostasis and the inflammatory response. Annu Rev Nutr. 2010;30:105–122.
   PubMed Web of Science ®Google Scholar
• Theurl I, Aigner E, Theurl M, et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009;113(21):5277–5286.
   PubMed Web of Science ®Google Scholar
• Roy CN, Mak HH, Akpan I, et al. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood. 2007;109(9):4038–4044.
   PubMed Web of Science ®Google Scholar
• Hashizume M, Uchiyama Y, Horai N, et al. Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-induced hepcidin production. Rheumatol Int. 2010;30(7):917–923.
   PubMed Web of Science ®Google Scholar
• Poli M, Asperti M, Ruzzenenti P, et al. Hepcidin antagonists for potential treatments of disorders with hepcidin excess. Front Pharmacol. 2014;5:86.
   PubMed Web of Science ®Google Scholar
• Leung DDM, Luan P, Manetta JV, et al. Anti-ferroportin 1 monoclonal antibodies and uses thereof. Google Patents; 2012.
   Google Scholar